Original Literature | Model OverView |
---|---|
Publication
Title
Nuclear factor-kappaB: activation and regulation during toll-like receptorsignaling.
Affiliation
Department of Pathology and Laboratory Medicine, School of Medicine, Universityof Pennsylvania, Philadelphia, PA 19104, USA. rcarmody@mail.med.upenn.edu
Abstract
Toll-like receptors (TLRs) recognize distinct microbial components to initiatethe innate and adaptive immune responses. TLR activation culminates in theexpression of appropriate pro-inflammatory and immunomodulatory factors to meetpathogenic challenges. The transcription factor NF-kappaB is the masterregulator of all TLR-induced responses and its activation is the pivotal eventin TLR-mediated activation of the innate immune response. Many of the keymolecular events required for TLR-induced NF-kappaB activation have beenelucidated. However, much remains to be learned about the ability of TLRs togenerate pathogen-specific responses using a limited number of transcriptionfactors. This review will focus on our current understanding of NF-kappaBactivation by TLRs and potential mechanisms for achieving a signal-specificresponse through NF-kappaB.
PMID
17349209
|
Entity
Process
RIP1
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m99
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
RelA-p65
--
MO000000193
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m166
10
infinite
0
TRANSPATH | MO000000193 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
IkappaB-alpha
--
MO000000233
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m199
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000233 |
--
IkappaB-beta
--
MO000000234
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m200
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000234 |
--
IkappaB-epsilon
--
MO000000237
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m203
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000237 |
--
Bcl-3
--
MO000000238
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m204
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000238 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
TAK1
--
MO000016574
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1573
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
A20
--
MO000016591
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1585
10
infinite
0
InterPro | IPR002653 |
TRANSPATH | MO000016591 |
--
IKK-gamma
--
MO000016599
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1593
10
infinite
0
InterPro | IPR007087 |
TRANSPATH | MO000016599 |
--
(p50)2
--
MO000016636
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1621
10
infinite
0
TRANSPATH | MO000016636 |
--
Tollip
--
MO000019406
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3973
10
infinite
0
InterPro | IPR000008 |
TRANSPATH | MO000019406 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
TAB2
--
MO000022125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6433
10
infinite
0
TRANSPATH | MO000022125 |
--
TIRAP
--
MO000022528
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6810
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000022528 |
--
TAB3
--
MO000041541
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19389
10
infinite
0
TRANSPATH | MO000041541 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
TNF-alpha:TNFR:RIP1{ub}
--
e100
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m103
0
infinite
0
--
TNF-alpha:TNFR:RIP1{ub}:IKK-gamma
--
e101
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m104
0
infinite
0
--
TLR3:TRIF:RIP1{ub}
--
e102
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m105
0
infinite
0
--
RelA-p65{p}
--
e104
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m108
0
infinite
0
--
PKA{active}
--
e105
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m109
0
infinite
0
--
PKA
--
e106
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m110
0
infinite
0
--
RelA-p65{p}:p300
--
e107
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m111
0
infinite
0
--
RelA-p65:CBP
--
e108
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m112
0
infinite
0
--
RelA-p65{ace}
--
e109
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m113
0
infinite
0
--
IkappaB{p}-NF-kappaB
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
p50{ace}
--
e111
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m115
0
infinite
0
--
IkappaB-alpha:p65
--
e113
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m117
0
infinite
0
--
IkappaB-alpha:p65
--
e114
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m118
0
infinite
0
--
IRF-3{active}
--
e115
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
NF-kappaB:AP1
--
e117
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m121
0
infinite
0
--
c/ebp:F-kappaB
--
e118
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m122
0
infinite
0
--
SP1
--
e119
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m123
0
infinite
0
--
IkappaB{p}{ub}:NF-kappaB
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
NF-kappaB:SP1
--
e120
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m124
0
infinite
0
--
NF-kappaB:SRF
--
e121
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m126
0
infinite
0
--
NF-kappaB:STAT6
--
e122
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m127
0
infinite
0
--
NF-kappaB:SEF
--
e123
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m128
0
infinite
0
--
SEF
--
e124
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m129
0
infinite
0
--
NF-kappaB:DNA:IRF3
--
e125
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m130
0
infinite
0
--
IL-12
--
e126
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m131
0
infinite
0
--
IkappaB
--
e127
cso30:c:mRNA
cso30:i:CC_Extracellular
--
csml-variable:Double
m132
0
infinite
0
--
IkappaB
--
e128
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m133
0
infinite
0
--
IkappaB
--
e129
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m134
0
infinite
0
--
NF-kappaB
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
NF-kappaB:IkappaB
--
e130
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m135
0
infinite
0
--
DNA:NF-kappaB{ub}
--
e132
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m137
0
infinite
0
--
protein remnants
--
e133
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m138
10
infinite
0
TRANSPATH | MO000019479 |
--
c-Rel{p}
--
e134
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m139
0
infinite
0
--
LPS:TLR4:Tollip
--
e135
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m140
0
infinite
0
--
TLR2 ligand:TLR2:TLR6:Tollip
--
e136
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m141
0
infinite
0
--
TLR4:TRAM:TRIF
--
e137
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m106
0
infinite
0
--
TLR3:TRIF:RIP1{ub}:TAB2:TAB3:TAK1
--
e138
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m142
0
infinite
0
--
NF-kappaB
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
csml-variable:Double
m15
0
infinite
0
--
DNA:NF-kappaB
--
e16
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m16
0
infinite
0
--
gene
--
e17
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
A20:IKK-gamma
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
IKK-gamma:RIP
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IKK-gamma{p}
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
TNF-alpha:TNFR
--
e21
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m21
0
infinite
0
--
IL1:IL1R
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m22
0
infinite
0
--
IL-1R
--
e23
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m23
0
infinite
0
--
IKK-gamma{ub}{sumo}:ATM
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
IKK-gamma{sumo}
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
IKK-gamma{sumo}
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
IKK-gamma{sumo}:ATM
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IKK-gamma{ub}{sumo}:ATM
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
NF-kappaB{active}
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
NF-kappaB:c-Rel
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
IkappaB-alpha:C-Rel:NF-kappaB
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
IkappaB-beta:C-Rel:NF-kappaB
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
p65:NF-kappaB
--
e33
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m33
0
infinite
0
--
IkappaB-alpha:p65:NF-kappaB
--
e34
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
IkappaB-beta:p65:NF-kappaB
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
C-Rel: p65
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
IkappaB-epsilon:C-Rel:p65
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
Bcl-3:(p50)2
--
e38
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m38
0
infinite
0
--
Bcl-3:(p52)2
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
(p52)2
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
IkappaB-zeta
--
e41
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m41
0
infinite
0
--
(p50)2:IkappaB-zeta
--
e42
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m42
0
infinite
0
--
p50:p65
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
p50:p65:IkappaB-zeta
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m44
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
TLR3 ligand
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m46
0
infinite
0
--
TLR3 ligand:TLR3
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
TLR3 ligand: TLR3: TRIF
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IkappaB-NF-kappaB
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
LPS:TLR4:TRAM
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
TLR1:TLR2
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
TLR2 ligand
--
e65
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m65
0
infinite
0
--
TLR2 ligand:TLR1:TLR2
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
TLR1:TLR2:TIRAP
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
TLR1:TLR2:TIRAP:MYD88
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m68
0
infinite
0
--
TLR2:TLR6
--
e69
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m69
0
infinite
0
--
LPS:TLR4
--
e7
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m7
0
infinite
0
--
TLR2ligand:TLR2:TLR6
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
TLR2 ligand:TLR2:TLR6:TIRAP
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
TLR2 ligand: TLR2:TLR6: TIRAP:MYD88
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
TLR7 ligand
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
TLR7 ligand: TLR7
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m74
0
infinite
0
--
TLR7 ligand:TLR7:MYD88
--
e75
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
e76
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m76
0
infinite
0
--
TLR8 ligand
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
TLR8 ligand:TLR8:MYD88
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
TLR9 ligand: TLR9
--
e79
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
LPS:TLR4:TIRAP
--
e8
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m8
0
infinite
0
--
TLR9 ligand
--
e80
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
TLR9 ligand:TLR9:MYD88
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m81
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
csml-variable:Double
m83
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:IRAK1{p}
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:IRAK1
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:IRAK1{p}:TRAF6
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:IRAK1{p}{ub}:TRAF6
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:TRAF6
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:TRAF6{ub}
--
e89
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
UBC13:Uev1A
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:TRAF6{ub}:TAB1:TAB2:TAB3
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m91
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:TRAF6{ub}:TAB1:TAB2:TAB3:TAK1
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
LPS:TLR4:TIRAP:MYD88:IRAK-4:TRAF6{ub}:TAB1:TAB2:TAB3:TAK1{active}
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
TLR3 ligand:TLR3:TRIF RIP1
--
e97
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m100
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:RIP1
--
e98
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m101
0
infinite
0
--
TNF-alpha:TNFR:RIP1
--
e99
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
m171*0.1
nodelay
--
0
PMID: 17349209 p50 is generated from limited proteasomal processing of the p105 protein as is p52 from the p100 protein.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m181*m182*m1593*0.1
nodelay
--
0
PMID: 17349209, 16987664 In addition to interacting with IKK¦Á and IKK¦Â, IKK¦Ã/NEMO also interacts with a number of proteins associated with NF-¦ÊB activation including RIP and A20.
p100
p100
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c279 : 1
stoichiometry:c281 : 1
stoichiometry:c280 : 1
m166*m181*0.1
nodelay
--
0
PMID: 17349209 IKK¦Á phosphorylation of p65 and c-Rel targets them for proteasomal degradation in the nucleus and is a key event in the termination of the NF-¦ÊB response to TLR stimulation.
p101
p101
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c282 : 1
stoichiometry:c283 : 1
m108*0.1
nodelay
--
0
PMID: 17349209 IKK¦Á phosphorylation of p65 and c-Rel targets them for proteasomal degradation in the nucleus and is a key event in the termination of the NF-¦ÊB response to TLR stimulation.
p102
p102
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c284 : 1
stoichiometry:c286 : 1
stoichiometry:c285 : 1
m165*m181*0.1
nodelay
--
0
PMID: 17349209 IKK¦Á phosphorylation of p65 and c-Rel targets them for proteasomal degradation in the nucleus and is a key event in the termination of the NF-¦ÊB response to TLR stimulation.
p103
p103
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c287 : 1
stoichiometry:c288 : 1
m139*0.1
nodelay
--
0
PMID: 17349209 IKK¦Á phosphorylation of p65 and c-Rel targets them for proteasomal degradation in the nucleus and is a key event in the termination of the NF-¦ÊB response to TLR stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c289 : 1
stoichiometry:c291 : 1
stoichiometry:c290 : 1
m7*m3973*0.1
nodelay
--
0
PMID: 17349209, 11751856 TOLLIP interacts with TLR2 and TLR4 as well as IRAK1 and interferes with the activation of NF-¦ÊB through MyD88-dependent pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c292 : 1
stoichiometry:c293 : 1
stoichiometry:c294 : 1
m3973*m70*0.1
nodelay
--
0
PMID: 17349209, 11751856 TOLLIP interacts with TLR2 and TLR4 as well as IRAK1 and interferes with the activation of NF-¦ÊB through MyD88-dependent pathways.
p106
p106
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c297 : 1
stoichiometry:c199 : 1
stoichiometry:c200 : 1
m1585*m100*0.1
nodelay
--
0
PMID: 17349209 In addition, a C-terminal ubiquitin ligase domain of A20 mediates the K48-polyubiquitination of RIP1 leading to its proteasomal degradation.
p107
p107
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c201 : 1
stoichiometry:c299 : 1
stoichiometry:c295 : 1
m105*0.1
nodelay
--
0
PMID: 17349209 In addition, a C-terminal ubiquitin ligase domain of A20 mediates the K48-polyubiquitination of RIP1 leading to its proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c300 : 1
stoichiometry:c302 : 1
stoichiometry:c301 : 1
m14*m100*0.1
nodelay
--
0
PMID: 17349209, 12471095 TLR3 instead exclusively uses the adaptor protein TRIF which binds directly to the receptor upon activation and is critical in the activation of NF-¦ÊB and the induction of interferon-¦Â expression through activation of IRF3.
p109
p109
cso30:i:ME_Deubiquitination
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c304 : 1
stoichiometry:c306 : 1
stoichiometry:c305 : 1
m89*m1585*0.1
nodelay
--
0
PMID: 17349209 The N-terminal domain of A20 contains a de-ubiquitinating activity which removes K63-polyubiquitin chains from both RIP1 and TRAF6, thereby inhibiting the recruitment and activation of the TAK1/TAB2/TAB3 complex.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m1593*m1585*0.1
nodelay
--
0
PMID: 17349209, 16987664 In addition to interacting with IKK¦Á and IKK¦Â, IKK¦Ã/NEMO also interacts with a number of proteins associated with NF-¦ÊB activation including RIP and A20.
p110
p110
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c309 : 1
stoichiometry:c310 : 1
stoichiometry:c311 : 1
stoichiometry:c312 : 1
stoichiometry:c314 : 1
stoichiometry:c313 : 1
m105*m19389*m6433*m1573*0.1
nodelay
--
0
PMID: 17349209 The N-terminal domain of A20 contains a de-ubiquitinating activity which removes K63-polyubiquitin chains from both RIP1 and TRAF6, thereby inhibiting the recruitment and activation of the TAK1/TAB2/TAB3 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c315 : 1
stoichiometry:c316 : 1
m107*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c318 : 1
m98*0.1
nodelay
--
0
--
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m1593*m179*0.1
nodelay
--
0
PMID: 17349209, 16987664 In addition to interacting with IKK¦Á and IKK¦Â, IKK¦Ã/NEMO also interacts with a number of proteins associated with NF-¦ÊB activation including RIP and A20.
p13
p13
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c37 : 1
stoichiometry:c61 : 1
stoichiometry:c33 : 1
m1593*m21*m182*0.1
nodelay
--
0
PMID: 17349209 The phosphorylation of IKK¦Ã/NEMO has been reported to occur following TNF-¦Á and IL-1 stimulation and appears to negatively regulate IKK activity. PMID: 17349209, 12657630, 11971901 The phosphorylation occurs primarily on serine 376 and is IKK¦Â dependent, indicating that this may be an autoregulatory mechanism.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m176*m230*0.1
nodelay
--
0
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m23*m185*0.1
nodelay
--
0
p16
p16
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c43 : 1
stoichiometry:c62 : 1
stoichiometry:c42 : 1
m1593*m22*m182*0.1
nodelay
--
0
PMID: 17349209 The phosphorylation of IKK¦Ã/NEMO has been reported to occur following TNF-¦Á and IL-1 stimulation and appears to negatively regulate IKK activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m27*0.1
nodelay
--
0
PMID: 17349209 The polyubiquitination of IKK¦Ã/NEMO occurs through K63-linked chains and does not target the protein for degradation but instead appears to serve as a posttranslational modification signal rather like phosphorylation. PMID: 17349209, 16497931 In the case of NEMO, sumolyation induces its nuclear localisation and interaction with the DNA damage sensor ATM which then triggers IKK¦Ã/NEMO mono-ubiquitination and nuclear export.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m1593*0.1
nodelay
--
0
PMID: 17349209, 14651848 The sumolyation of IKK¦Ã/NEMO has been identified as an important mechanism for the activation of NF-¦ÊB in response to genotoxic stress
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m25*0.1
nodelay
--
0
PMID: 17349209, 16497931 In the case of NEMO, sumolyation induces its nuclear localisation and interaction with the DNA damage sensor ATM which then triggers IKK¦Ã/NEMO mono-ubiquitination and nuclear export.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
m173*0.1
nodelay
--
0
PMID: 17349209 p50 is generated from limited proteasomal processing of the p105 protein as is p52 from the p100 protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m26*m10494*0.1
nodelay
--
0
PMID: 17349209, 16497931 In the case of NEMO, sumolyation induces its nuclear localisation and interaction with the DNA damage sensor ATM which then triggers IKK¦Ã/NEMO mono-ubiquitination and nuclear export.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m24*0.1
nodelay
--
0
PMID: 17349209, 16497931 In the case of NEMO, sumolyation induces its nuclear localisation and interaction with the DNA damage sensor ATM which then triggers IKK¦Ã/NEMO mono-ubiquitination and nuclear export.
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m207*m28*0.1
nodelay
--
0
PMID: 17349209 The cytoplasmic IKK¦Ã/NEMO and ATM complex then activates the IKK complex and NF-¦ÊB through an unknown mechanism.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c60 : 1
stoichiometry:c59 : 1
m14*m28*0.1
nodelay
--
0
PMID: 17349209 The cytoplasmic IKK¦Ã/NEMO and ATM complex then activates the IKK complex and NF-¦ÊB through an unknown mechanism.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m199*m30*0.1
nodelay
--
0
PMID: 17349209, 2691328, 7867065, 1340770 I¦ÊB¦Á and I¦ÊB¦Â preferentially bind c-Rel and p65 containing dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c67 : 1
m200*m30*0.1
nodelay
--
0
PMID: 17349209, 2691328, 7867065, 1340770 I¦ÊB¦Á and I¦ÊB¦Â preferentially bind c-Rel and p65 containing dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m199*m33*0.1
nodelay
--
0
PMID: 17349209, 2691328, 7867065, 1340770 I¦ÊB¦Á and I¦ÊB¦Â preferentially bind c-Rel and p65 containing dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m200*m33*0.1
nodelay
--
0
PMID: 17349209, 2691328, 7867065, 1340770 I¦ÊB¦Á and I¦ÊB¦Â preferentially bind c-Rel and p65 containing dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m203*m36*0.1
nodelay
--
0
PMID: 17349209, 9135156 I¦ÊB¦Å only binds c-Rel and p65 complexes.
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m1621*m204*0.1
nodelay
--
0
PMID: 17349209, 8336935, 8497270 Bcl-3 binds only p50 and p52 homodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m207*0.1
nodelay
--
0
PMID: 17349209 Activation of the IKK complex induces phosphorylation of the I¦ÊB proteins, leading to their K48-polyubiquitination and proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m204*m40*0.1
nodelay
--
0
PMID: 17349209, 8336935, 8497270 Bcl-3 binds only p50 and p52 homodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m1621*m41*0.1
nodelay
--
0
PMID: 17349209, 17027520 I¦ÊB¦Æ binds both p50 homodimers and p65/p50 dimers. PMID: 17349209, 15241416 I¦ÊB¦Æ is itself a TLR inducible gene which associates with p50 and is critical for the induction of the pro-inflammatory cytokines IL-6 and IL-12 following TLR stimulation in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m41*m43*0.1
nodelay
--
0
PMID: 17349209, 17027520 I¦ÊB¦Æ binds both p50 homodimers and p65/p50 dimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m157177*m3961*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m7*m6810*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c104 : 1
m8*m1572*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m3965*m46*0.1
nodelay
--
0
PMID: 17349209 TRIF is associated only with TLR4 and TLR3, binding directly to TLR3 and using the bridging adaptor TRAM to bind to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m18998*m47*0.1
nodelay
--
0
PMID: 17349209 TRIF is associated only with TLR4 and TLR3, binding directly to TLR3 and using the bridging adaptor TRAM to bind to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m7*m19005*0.1
nodelay
--
0
PMID: 17349209 TRIF is associated only with TLR4 and TLR3, binding directly to TLR3 and using the bridging adaptor TRAM to bind to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m63*m18998*0.1
nodelay
--
0
PMID: 17349209 TRIF is associated only with TLR4 and TLR3, binding directly to TLR3 and using the bridging adaptor TRAM to bind to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c8 : 1
m6*m5*0.1
nodelay
--
0
PMID: 17349209 Activation of the IKK complex induces phosphorylation of the I¦ÊB proteins, leading to their K48-polyubiquitination and proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m64*m65*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m6810*m66*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m67*m1572*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
stoichiometry:c122 : 1
m69*m65*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m70*m6810*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m71*m1572*0.1
nodelay
--
0
PMID: 17349209 TIRAP acts as a bridging adaptor between TLR4, TLR1/2, TLR2/6 and MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c131 : 1
stoichiometry:c130 : 1
m19940*m73*0.1
nodelay
--
0
PMID: 17349209 MyD88 interacts with TLRs 7, 8 and 9 via its C-terminal TIR domain and associates with all the other TLRs through the bridging adaptor TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
stoichiometry:c134 : 1
m74*m1572*0.1
nodelay
--
0
PMID: 17349209 MyD88 interacts with TLRs 7, 8 and 9 via its C-terminal TIR domain and associates with all the other TLRs through the bridging adaptor TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c137 : 1
stoichiometry:c136 : 1
m19823*m77*0.1
nodelay
--
0
PMID: 17349209 MyD88 interacts with TLRs 7, 8 and 9 via its C-terminal TIR domain and associates with all the other TLRs through the bridging adaptor TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m76*m1572*0.1
nodelay
--
0
PMID: 17349209 MyD88 interacts with TLRs 7, 8 and 9 via its C-terminal TIR domain and associates with all the other TLRs through the bridging adaptor TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m11*0.1
nodelay
--
0
PMID: 17349209 Activation of the IKK complex induces phosphorylation of the I¦ÊB proteins, leading to their K48-polyubiquitination and proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c143 : 1
stoichiometry:c142 : 1
m19828*m80*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c146 : 1
stoichiometry:c145 : 1
m79*m1572*0.1
nodelay
--
0
PMID: 17349209 MyD88 interacts with TLRs 7, 8 and 9 via its C-terminal TIR domain and associates with all the other TLRs through the bridging adaptor TIRAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m17258*m45*0.1
nodelay
--
0
PMID: 17349209 MyD88 also binds to the kinase IRAK4 through death domains contained in both proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c151 : 1
m85*0.1
nodelay
--
0
PMID: 17349209 Receptor associated IRAK4 subsequently phosphorylates IRAK1, which in turn complexes with the E3 ubiquitin ligase TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c152 : 1
stoichiometry:c153 : 1
m82*m83*0.1
nodelay
--
0
PMID: 17349209 This allows the formation of a complex which includes IRAK1, IRAK4 and TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m84*m183*0.1
nodelay
--
0
PMID: 17349209 Receptor associated IRAK4 subsequently phosphorylates IRAK1, which in turn complexes with the E3 ubiquitin ligase TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m86*0.1
nodelay
--
0
PMID: 17349209, 9261174 Phosphorylated IRAK1 undergoes ubiquitination and proteasomal degradation which most likely serves as a negative feedback loop for TRAF6 activation
p57
p57
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m87*0.1
nodelay
--
0
PMID: 17349209, 9261174 Phosphorylated IRAK1 undergoes ubiquitination and proteasomal degradation which most likely serves as a negative feedback loop for TRAF6 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c165 : 1
stoichiometry:c164 : 1
m88*m90*0.1
nodelay
--
0
PMID: 17349209, 11460167 Activated TRAF6 undergoes K63-mediated polyubiquitination which differs from the K48 form of polyubiquitination in that it does not lead to proteasomal degradation. PMID: 17349209 The polyubiquitination of TRAF6 appears to be mediated by an E2 complex containing UBC13 and UEV1A.
p59
p59
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
stoichiometry:c169 : 1
stoichiometry:c307 : 1
stoichiometry:c170 : 1
m89*m1583*m6433*m19389*0.1
nodelay
--
0
PMID: 17349209 The exact role of TRAF6 polyubiquitination is unclear but it appears to be necessary for the recruitment of TAB1, TAB2 and TAB3. PMID: 17349209 The N-terminal domain of A20 contains a de-ubiquitinating activity which removes K63-polyubiquitin chains from both RIP1 and TRAF6, thereby inhibiting the recruitment and activation of the TAK1/TAB2/TAB3 complex.
p6
p6
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m12*0.1
nodelay
--
0
PMID: 17349209 Activation of the IKK complex induces phosphorylation of the I¦ÊB proteins, leading to their K48-polyubiquitination and proteasomal degradation.
p60
p60
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c172 : 1
stoichiometry:c308 : 1
stoichiometry:c173 : 1
m91*m1573*0.1
nodelay
--
0
PMID: 17349209, 11460167, 14633987, 14670075 Both TAB2 and TAB3 proteins share the ability to interact with and activate the kinase TAK1. PMID: 17349209 The N-terminal domain of A20 contains a de-ubiquitinating activity which removes K63-polyubiquitin chains from both RIP1 and TRAF6, thereby inhibiting the recruitment and activation of the TAK1/TAB2/TAB3 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m92*0.1
nodelay
--
0
PMID: 17349209, 11460167, 14633987, 14670075 Both TAB2 and TAB3 proteins share the ability to interact with and activate the kinase TAK1. PMID: 17349209 The mechanism of TAK1 activation by recruitment to the TRAF6/TAB2/TAB3 complex is unclear but it may involve a trans-autophosphorylation event induced by dimerisation or oligomerisation.
p62
p62
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c178 : 1
stoichiometry:c177 : 1
m94*m93*0.1
nodelay
--
0
PMID: 17349209, 16186825 In addition to NF-¦ÊB activation, TAK1 is also required for the activation of JNK and p38 and subsequent AP-1 activity following TLR stimulation.
p63
p63
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c181 : 1
stoichiometry:c180 : 1
m96*m93*0.1
nodelay
--
0
PMID: 17349209, 16186825 In addition to NF-¦ÊB activation, TAK1 is also required for the activation of JNK and p38 and subsequent AP-1 activity following TLR stimulation.
p64
p64
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c184 : 1
stoichiometry:c183 : 1
m219*m93*0.1
nodelay
--
0
PMID: 17349209, 16186825 In addition to NF-¦ÊB activation, TAK1 is also required for the activation of JNK and p38 and subsequent AP-1 activity following TLR stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c186 : 1
stoichiometry:c187 : 1
m48*m99*0.1
nodelay
--
0
PMID: 17349209 In this case, RIP1 binds to a RIP homotypic interaction motif (RHIM) in TRIF to trigger downstream NF-¦ÊB activating events.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
stoichiometry:c190 : 1
m49*m99*0.1
nodelay
--
0
PMID: 17349209 In this case, RIP1 binds to a RIP homotypic interaction motif (RHIM) in TRIF to trigger downstream NF-¦ÊB activating events.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m21*m99*0.1
nodelay
--
0
PMID: 17349209, 10755617, 16543241, 16547522 RIP1 has been reported to be K63-polyubiquitinated upon recruitment to the TNFR which facilitates its interaction with IKK¦Ã via a C-terminal ubiquitin binding domain in IKK¦Ã
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
m102*0.1
nodelay
--
0
PMID: 17349209, 10755617, 16543241, 16547522 RIP1 has been reported to be K63-polyubiquitinated upon recruitment to the TNFR which facilitates its interaction with IKK¦Ã via a C-terminal ubiquitin binding domain in IKK¦Ã
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m103*m1593*0.1
nodelay
--
0
PMID: 17349209, 10755617, 16543241, 16547522 RIP1 has been reported to be K63-polyubiquitinated upon recruitment to the TNFR which facilitates its interaction with IKK¦Ã via a C-terminal ubiquitin binding domain in IKK¦Ã
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c16 : 1
m29*0.1
nodelay
--
0
PMID: 17349209 The degradation of I¦ÊB protein allows for translocation of the liberated NF-¦ÊB dimers to the nucleus where they bind their cognate sites in DNA and activate gene transcription.
p70
p70
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c296 : 1
stoichiometry:c303 : 1
stoichiometry:c298 : 1
m105*m1585*0.1
nodelay
--
0
PMID: 17349209 The N-terminal domain of A20 contains a de-ubiquitinating activity which removes K63-polyubiquitin chains from both RIP1 and TRAF6, thereby inhibiting the recruitment and activation of the TAK1/TAB2/TAB3 complex.
p71
p71
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c204 : 1
stoichiometry:c203 : 1
m977*m100*0.1
nodelay
--
0
PMID: 17349209, 12471095 TLR3 instead exclusively uses the adaptor protein TRIF which binds directly to the receptor upon activation and is critical in the activation of NF-¦ÊB and the induction of interferon-¦Â expression through activation of IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c317 : 1
stoichiometry:c206 : 1
m119*0.1
nodelay
--
0
PMID: 17349209, 12471095 TLR3 instead exclusively uses the adaptor protein TRIF which binds directly to the receptor upon activation and is critical in the activation of NF-¦ÊB and the induction of interferon-¦Â expression through activation of IRF3.
p73
p73
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c209 : 1
stoichiometry:c208 : 1
m166*m109*0.1
nodelay
--
0
PMID: 17349209, 9150141, 11931769 Phosphorylation of S276 in the Rel homology domain of p65 by protein kinase A is an important regulatory event which occurs during TLR4 signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c211 : 1
m110*m7*0.1
nodelay
--
0
PMID: 17349209, 9150141, 11931769 Phosphorylation of S276 in the Rel homology domain of p65 by protein kinase A is an important regulatory event which occurs during TLR4 signaling.
p75
p75
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c215 : 1
stoichiometry:c214 : 1
m108*m4512*0.1
nodelay
--
0
PMID: 17349209, 8246997, 8437855 In addition, S276 phosphorylation enhances the binding of the transcriptional enhancers CBP and p300 to p65, leading to effective removal of repressive histone deacetylase complexes from target genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c216 : 1
stoichiometry:c217 : 1
stoichiometry:c218 : 1
m2282*m108*0.1
nodelay
--
0
PMID: 17349209, 8246997, 8437855 In addition, S276 phosphorylation enhances the binding of the transcriptional enhancers CBP and p300 to p65, leading to effective removal of repressive histone deacetylase complexes from target genes
p77
p77
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c221 : 1
stoichiometry:c220 : 1
m166*m182*0.1
nodelay
--
0
PMID: 17349209, 12759443 IKK¦Â has been identified as the key kinase in the TLR4-induced phosphorylation of p65 on S536.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c223 : 1
m166*0.1
nodelay
--
0
PMID: 17349209, 12456660 Three primary acetylation sites have been identified in p65, i.e., K218, K221 and K310, each of which has a distinct modulatory effect on the transcriptional activities of NF-¦ÊB
p79
p79
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c227 : 1
stoichiometry:c229 : 1
stoichiometry:c228 : 1
m166*m116*0.1
nodelay
--
0
PMID: 17349209, 11533489 Acetylation of p65 on K218 and K221 significantly reduces its ability to interact with I¦ÊB¦Á, thereby extending the duration of the NF-¦ÊB response in the nucleus by preventing the nuclear export of NF-¦ÊB/I¦ÊB¦Á complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m13*m15*0.1
nodelay
--
0
PMID: 17349209 The degradation of I¦ÊB protein allows for translocation of the liberated NF-¦ÊB dimers to the nucleus where they bind their cognate sites in DNA and activate gene transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c319 : 1
stoichiometry:c226 : 1
m172*0.1
nodelay
--
0
PMID: 17349209, 11739381, 12471036 The p50 subunit of NF-¦ÊB is also acetylated, at K431 and K440, which appears to enhance the transcriptional activity and DNA binding activity of modified heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c232 : 1
stoichiometry:c231 : 1
m117*0.1
nodelay
--
0
PMID: 17349209, 11533489 Acetylation of p65 on K218 and K221 significantly reduces its ability to interact with I¦ÊB¦Á, thereby extending the duration of the NF-¦ÊB response in the nucleus by preventing the nuclear export of NF-¦ÊB/I¦ÊB¦Á complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c245 : 1
stoichiometry:c235 : 1
m120*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c239 : 1
stoichiometry:c237 : 1
m3981*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c234 : 1
stoichiometry:c241 : 1
m123*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c236 : 1
stoichiometry:c244 : 1
m125*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c248 : 1
stoichiometry:c247 : 1
m1368*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c250 : 1
stoichiometry:c251 : 1
stoichiometry:c249 : 1
m129*m13*0.1
nodelay
--
0
PMID: 17349209, 8321203, 8798413, 8404856, 8253080, 7935378, 8670842, 9584180, 10899169 NF-¦ÊB has been reported to interact with a number of transcription factors, including C/EBP , AP-1, Sp-1, SRF , STAT6 and SEF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c242 : 1
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m119*m16*0.1
nodelay
--
0
PMID: 17349209, 16143103 NF-¦ÊB has been shown to directly interact with TRIF-activated IRF3 on target promoters.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c254 : 1
m42*0.1
nodelay
--
0
PMID: 17349209, 15241416 I¦ÊB¦Æ is itself a TLR inducible gene which associates with p50 and is critical for the induction of the pro-inflammatory cytokines IL-6 and IL-12 following TLR stimulation in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m16*0.1
nodelay
--
0
PMID: 17349209 The degradation of I¦ÊB protein allows for translocation of the liberated NF-¦ÊB dimers to the nucleus where they bind their cognate sites in DNA and activate gene transcription.
p90
p90
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c256 : 1
stoichiometry:c258 : 1
stoichiometry:c257 : 1
m93248*m42*0.1
nodelay
--
0
PMID: 17349209, 15241416 I¦ÊB¦Æ is itself a TLR inducible gene which associates with p50 and is critical for the induction of the pro-inflammatory cytokines IL-6 and IL-12 following TLR stimulation in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c262 : 1
stoichiometry:c260 : 1
m42*0.1
nodelay
--
0
PMID: 17349209, 15241416 I¦ÊB¦Æ is itself a TLR inducible gene which associates with p50 and is critical for the induction of the pro-inflammatory cytokines IL-6 and IL-12 following TLR stimulation in macrophages.
p92
p92
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c261 : 1
stoichiometry:c263 : 1
stoichiometry:c259 : 1
m131*m42*0.1
nodelay
--
0
PMID: 17349209, 15241416 I¦ÊB¦Æ is itself a TLR inducible gene which associates with p50 and is critical for the induction of the pro-inflammatory cytokines IL-6 and IL-12 following TLR stimulation in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c264 : 1
stoichiometry:c265 : 1
m13*0.1
nodelay
--
0
PMID: 17349209 The de novo synthesis of the I¦ÊB proteins in an NF-¦ÊB-dependent manner constitutes a negative feedback loop for NF-¦ÊB activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c266 : 1
stoichiometry:c267 : 1
m132*0.1
nodelay
--
0
PMID: 17349209 The de novo synthesis of the I¦ÊB proteins in an NF-¦ÊB-dependent manner constitutes a negative feedback loop for NF-¦ÊB activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c268 : 1
stoichiometry:c269 : 1
m133*0.1
nodelay
--
0
PMID: 17349209, 15900032 Newly synthesized I¦ÊB proteins enter the nucleus via a nuclear localization signal where they bind free NF-¦ÊB dimers and translocate to the cytoplasm as an I¦ÊB/NF-¦ÊB complex using a nuclear export sequence, thereby terminating NF-¦ÊB transcriptional activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c270 : 1
stoichiometry:c271 : 1
stoichiometry:c272 : 1
m134*m13*0.1
nodelay
--
0
PMID: 17349209, 15900032 Newly synthesized I¦ÊB proteins enter the nucleus via a nuclear localization signal where they bind free NF-¦ÊB dimers and translocate to the cytoplasm as an I¦ÊB/NF-¦ÊB complex using a nuclear export sequence, thereby terminating NF-¦ÊB transcriptional activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c273 : 1
stoichiometry:c274 : 1
m135*0.1
nodelay
--
0
PMID: 17349209, 15900032 Newly synthesized I¦ÊB proteins enter the nucleus via a nuclear localization signal where they bind free NF-¦ÊB dimers and translocate to the cytoplasm as an I¦ÊB/NF-¦ÊB complex using a nuclear export sequence, thereby terminating NF-¦ÊB transcriptional activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c275 : 1
stoichiometry:c276 : 1
m16*0.1
nodelay
--
0
PMID: 17349209, 15226358 The second mechanism of limiting NF-¦ÊB activity was initially discovered in studies of I¦ÊB¦Á knockout cells and involves the ubiquitin targeted proteasomal degradation of promoter bound NF-¦ÊB.
p99
p99
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c277 : 1
stoichiometry:c278 : 1
m137*0.1
nodelay
--
0
PMID: 17349209, 15226358 The second mechanism of limiting NF-¦ÊB activity was initially discovered in studies of I¦ÊB¦Á knockout cells and involves the ubiquitin targeted proteasomal degradation of promoter bound NF-¦ÊB.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--